Seminars in Oncology Hematology

Early hepatic decompensation is associated with mortality in patients with HCC treated with atezolizumab plus bevacizumab or durvalumab plus tremelimumab

Elsevier ·

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →